Aliases & Classifications for Gastroenteritis

MalaCards integrated aliases for Gastroenteritis:

Name: Gastroenteritis 12 72 51 40 41 14 69
Cholera Morbus 12 69
Infectious Colitis, Enteritis and Gastroenteritis 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2326
ICD10 32 K52.9
MeSH 41 D005759
NCIt 46 C34632

Summaries for Gastroenteritis

MedlinePlus : 40 Have you ever had the "stomach flu?" What you probably had was gastroenteritis - not a type of flu at all. Gastroenteritis is an inflammation of the lining of the intestines caused by a virus, bacteria or parasites. Viral gastroenteritis is the second most common illness in the U.S. The cause is often a norovirus infection. It spreads through contaminated food or water, and contact with an infected person. The best prevention is frequent hand washing. Symptoms of gastroenteritis include diarrhea, abdominal pain, vomiting, headache, fever and chills. Most people recover with no treatment. The most common problem with gastroenteritis is dehydration. This happens if you do not drink enough fluids to replace what you lose through vomiting and diarrhea. Dehydration is most common in babies, young children, the elderly and people with weak immune systems. NIH: National Institute of Diabetes and Digestive and Kidney Diseases

MalaCards based summary : Gastroenteritis, also known as cholera morbus, is related to eosinophilic gastroenteritis and acute pancreatitis, and has symptoms including gastrointestinal gas, gastric irritation and signs and symptoms, digestive. An important gene associated with Gastroenteritis is ANPEP (Alanyl Aminopeptidase, Membrane), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Fentanyl and Infliximab have been mentioned in the context of this disorder. Affiliated tissues include colon, testes and bone, and related phenotypes are immune system and digestive/alimentary

Disease Ontology : 12 A gastrointestinal system infectious disease that involves inflammation of the lining of the stomach and small and large intestines, which is caused by viruses, bacteria, or parasites. Chemicals and drugs also cause gastroenteritis. The symptoms include diarrhea, loss of appetite, nausea, vomiting, cramps, and discomfort in the abdomen.

Wikipedia : 72 Gastroenteritis, also known as infectious diarrhea, is inflammation of the gastrointestinal tract that... more...

Related Diseases for Gastroenteritis

Diseases related to Gastroenteritis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 525)
# Related Disease Score Top Affiliating Genes
1 eosinophilic gastroenteritis 34.0 ALB CCL11 IL5 RNASE3
2 acute pancreatitis 30.4 CRP CXCL8 IL10 IL6
3 esophagitis 30.3 CCL11 CXCL8 IL1B IL5 IL6
4 esophagitis, eosinophilic, 1 30.3 CCL11 IL5 RNASE3
5 duodenal ulcer 30.2 CXCL8 IL1B TNF
6 colitis 30.1 CXCL8 IFNG IL10 IL1B IL4 IL6
7 laryngitis 30.0 IL1B IL6 TNF
8 diversion colitis 30.0 CDH1 IL1B IL4
9 cystitis 30.0 CRP CXCL8 IL6 TNF
10 obstructive jaundice 30.0 ALB CXCL8 IL6 TNF
11 eosinophilic gastritis 29.8 CCL11 IL4 IL5
12 trichuriasis 29.8 CXCL8 IL10 TNF
13 milk allergy 29.8 IL10 IL4 IL5 RNASE3
14 reactive arthritis 29.7 CRP IFNG IL10 IL6 TNF
15 churg-strauss syndrome 29.7 IL10 IL5 RNASE3 TNF
16 cholangitis 29.7 ALB CRP FUT2 IL6 TNF
17 alcoholic liver cirrhosis 29.6 ALB CXCL8 TNF
18 eosinophilic pneumonia 29.6 CCL11 IL5 RNASE3
19 proctitis 29.6 CRP RNASE3 TNF
20 listeriosis 29.6 CDH1 IL10 IL6 TNF
21 sclerosing cholangitis 29.6 ALB FUT2 TNF
22 hypereosinophilic syndrome 29.5 CCL11 CXCL8 IFNA1 IL5 RNASE3
23 salmonellosis 29.5 ALB IFNG IL1B
24 arthritis 29.5 CXCL8 IFNG IL10 IL1B IL6 TNF
25 aspergillosis 29.4 IFNG IL10 IL4 IL5
26 perinatal necrotizing enterocolitis 29.4 CRP CXCL8 IL1B IL6 TNF
27 bullous pemphigoid 29.3 CCL11 IL5 RNASE3
28 food allergy 29.3 ALB IFNG IL10 IL4 IL5 RNASE3
29 crohn's disease 29.3 CRP IFNG IL10 IL1B IL6 TNF
30 connective tissue disease 29.2 IFNG IL10 IL6 TNF
31 celiac disease 1 29.2 ALB IFNG IL10 TNF
32 cytomegalovirus infection 29.1 CXCL8 IFNG IL10 IL6 TNF
33 dermatitis 29.1 CCL11 IFNG IL4 IL5 RNASE3
34 graft-versus-host disease 29.0 IFNG IL10 IL1B IL6 TNF
35 bronchitis 29.0 ALB CCL11 CXCL8 IL5 RNASE3 TNF
36 helicobacter pylori infection 29.0 CXCL8 IFNG IL10 IL1B TNF
37 skin disease 29.0 CXCL8 IFNG IL10 IL4 TNF
38 severe acute respiratory syndrome 28.9 CXCL8 IFNA1 IFNG TNF
39 pyelonephritis 28.9 ALB CRP CXCL8 IL10 IL1B IL6
40 appendicitis 28.9 ALB CRP CXCL8 IL10 IL1B IL6
41 typhoid fever 28.8 ALB CRP IFNG IL1B IL6 TNF
42 tonsillitis 28.8 CXCL8 IFNG IL1B IL4 IL6 TNF
43 peritonitis 28.7 ALB CRP CXCL8 IFNG IL10 IL1B
44 ulcerative colitis 28.6 CRP CXCL8 IFNG IL10 IL1B IL6
45 allergic asthma 28.4 CCL11 CXCL8 IFNG IL10 IL4 IL5
46 intestinal disease 28.3 ALB CRP CXCL8 IFNG IL10 IL1B
47 rheumatoid arthritis 28.3 CRP CXCL8 IFNG IL10 IL1B IL4
48 endocarditis 28.3 ALB CRP CXCL8 IL10 IL6 LACTB
49 asthma 28.0 CCL11 CXCL8 IFNG IL10 IL1B IL4
50 multiple sclerosis 28.0 IFNA1 IFNG IL10 IL1B IL4 IL5

Graphical network of the top 20 diseases related to Gastroenteritis:



Diseases related to Gastroenteritis

Symptoms & Phenotypes for Gastroenteritis

UMLS symptoms related to Gastroenteritis:


gastrointestinal gas, gastric irritation, signs and symptoms, digestive, pruritus, nausea and vomiting, icterus, heartburn, fever, dyspepsia, diarrhea, constipation, abdominal pain, abdominal cramps

MGI Mouse Phenotypes related to Gastroenteritis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 10.1 ANPEP CCL11 CDH1 CRP FUT2 IFNG
2 digestive/alimentary MP:0005381 10.02 ALB CDH1 FUT2 IFNG IL10 IL4
3 integument MP:0010771 9.86 ANPEP CDH1 IFNG IL10 IL1B IL4
4 liver/biliary system MP:0005370 9.7 TNF ALB IFNG IL10 IL4 IL5
5 neoplasm MP:0002006 9.56 TNF ALB CDH1 IFNG IL10 IL1B
6 reproductive system MP:0005389 9.28 ANPEP CDH1 FUT2 IFNG IL10 IL4

Drugs & Therapeutics for Gastroenteritis

Drugs for Gastroenteritis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 782)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 437-38-7 3345
2
Infliximab Approved Phase 4,Phase 3,Phase 2,Phase 1 170277-31-3
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
4
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 1400-61-9 11953884
5
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-23-7 657311 5754
6
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 53-03-2 5865
7
Certolizumab pegol Approved Phase 4,Phase 3,Phase 2,Phase 1 428863-50-7
8
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
10
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
11
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 2 26787-78-0 33613 2171
12
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
13
Metronidazole Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 443-48-1 4173
14
Azathioprine Approved Phase 4,Phase 3,Phase 2,Phase 1 446-86-6 2265
15
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
16
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 51-45-6, 75614-87-8 774
17
Mianserin Approved, Investigational Phase 4 24219-97-4 4184
18
Mirtazapine Approved Phase 4 85650-52-8, 61337-67-5 4205
19
Clarithromycin Approved Phase 4,Phase 2,Phase 3 81103-11-9 84029
20
Rabeprazole Approved, Investigational Phase 4,Phase 2,Phase 3 117976-89-3 5029
21
Sucralfate Approved Phase 4,Phase 3,Early Phase 1 54182-58-0 0
22
Clofazimine Approved, Investigational Phase 4,Phase 3 2030-63-9 2794
23
Rifabutin Approved, Investigational Phase 4,Phase 3 72559-06-9 6323490
24
Ertapenem Approved, Investigational Phase 4,Phase 2,Early Phase 1 153832-46-3 150610
25
Budesonide Approved Phase 4,Phase 3,Phase 2 51333-22-3 5281004 63006
26
Dopamine Approved Phase 4,Phase 3,Phase 2,Phase 1 51-61-6, 62-31-7 681
27
Metoclopramide Approved, Investigational Phase 4,Phase 3 364-62-5 4168
28
Ondansetron Approved Phase 4,Phase 3,Phase 2,Phase 1 99614-02-5 4595
29
Loperamide Approved Phase 4,Phase 3,Phase 2,Phase 1 53179-11-6 3955
30
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2 7440-66-6 32051 23994
31 Zinc sulfate Approved, Investigational Phase 4,Phase 2,Phase 3 7733-02-0
32
Calcium Carbonate Approved, Investigational Phase 4 471-34-1
33
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
34
Menthol Approved Phase 4,Phase 1,Phase 2 2216-51-5 16666
35
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 2078-54-8 4943
36
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 73590-58-6 4594
37
Rosiglitazone Approved, Investigational Phase 4,Phase 1,Phase 2 122320-73-4 77999
38
Esomeprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 161796-78-7, 119141-88-7 9579578 4594
39
Dexlansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 138530-94-6, 103577-45-3 9578005
40
Lansoprazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 103577-45-3 3883
41
Hydroxocobalamin Approved Phase 4,Phase 2 13422-51-0 5460373 44475014 11953898
42
Morphine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 57-27-2 5288826
43
Methotrexate Approved Phase 4,Phase 2,Phase 3,Phase 1 1959-05-2, 59-05-2 126941
44
Rifaximin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 80621-81-4 6436173
45
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1 7439-89-6 23925
46
Ropivacaine Approved Phase 4,Phase 1,Phase 2 84057-95-4 175805 71273
47
Melphalan Approved Phase 4,Phase 3,Phase 2,Phase 1 148-82-3 460612 4053
48
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-02-2 5743
49
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 564-25-0 54671203
50
Aminosalicylic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1 65-49-6 4649

Interventional clinical trials:

(show top 50) (show all 3078)

# Name Status NCT ID Phase Drugs
1 Analgesic Efficacy of Intravenous Hyoscine-N-Butylbromide (HNB) in Abdominal Colic Associated With Acute Gastroenteritis Unknown status NCT02508142 Phase 4 Hyoscine-N-Butylbromide
2 Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab Unknown status NCT02453776 Phase 4 PRECISION dosing Infliximab
3 Withholding Feeds During Red Blood Cell Transfusion and TRAGI Unknown status NCT02132819 Phase 4
4 Confocal Endomicroscopy During Endoscopy Unknown status NCT00988273 Phase 4
5 Oral Hygiene Regimen in Patients on HCT Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
6 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Unknown status NCT02452151 Phase 4 Infliximab-Biosimilar;Infliximab-Innovator
7 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Unknown status NCT01876407 Phase 4
8 The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) Unknown status NCT01765998 Phase 4 Probiotic;Placebo
9 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Unknown status NCT01078935 Phase 4
10 Effects of Enteral Nutrition and Corticosteroid on Intestinal Flora in Induction Remission of Crohn Disease in Adult Unknown status NCT02056418 Phase 4 corticosteroid
11 Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission Unknown status NCT01817426 Phase 4 Infliximab
12 A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Unknown status NCT01632462 Phase 4 VSL#3
13 Optimizing Cimzia in Crohn's Patients Unknown status NCT01024647 Phase 4
14 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Unknown status NCT00851565 Phase 4
15 Evaluation of PET CT in the Management of Patients With Crohn's Disease. Unknown status NCT00731809 Phase 4
16 Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease Unknown status NCT00609752 Phase 4 prednisolone
17 VSL#3 Treatment in Children With Crohn's Disease Unknown status NCT00367705 Phase 4
18 Diverticulitis: Antibiotics or Close Observation? Unknown status NCT01111253 Phase 4 Amoxicillin-clavulanate
19 Comparison of a Nutritional Anti-Inflammatory Treatment to Steroids for Pediatric Crohn's Disease - the Molecular Basis Unknown status NCT00265772 Phase 4 MODULEN IBD (R) (specific Enteral Nutrition);prednisolon
20 A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis Unknown status NCT02425852 Phase 4 Azathioprine;Infliximab;Prednisolone;Hydrocortisone
21 The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis Unknown status NCT01278017 Phase 4 ceftriaxone
22 Mirtazapine Versus Placebo in Functional Dyspepsia Unknown status NCT01240096 Phase 4 Mirtazapine
23 Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Unknown status NCT02412085 Phase 4 Golimumab
24 Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Unknown status NCT02186886 Phase 4 Golimumab
25 Concomitant Therapy of H. Pylori Unknown status NCT01922765 Phase 4 amoxicillin, clarithromycin, metronidazole, rabeprazole
26 Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe Unknown status NCT01630096 Phase 4 Nu-Lytely
27 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4 Probiotic
28 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
29 Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis Unknown status NCT00513552 Phase 4 Rifabutin, Clarithromycin, and Clofazimine
30 Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis Unknown status NCT02371941 Phase 4 oral cromolyn sodium;Placebo
31 Antibiotics Versus Surgery in Acute Appendicitis Unknown status NCT01421901 Phase 4 Ertapenem
32 Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis Unknown status NCT01846962 Phase 4 Budesonide;Fluticasone
33 Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis Unknown status NCT00097734 Phase 4 ertapenem
34 Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France. Completed NCT00740935 Phase 4
35 Ondansetron Versus Metoclopramide in Treatment of Vomiting in Gastroenteritis Completed NCT01165866 Phase 4 Treatment 1. Metoclopramide;Treatment 2 Ondansetron
36 Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis Completed NCT02025452 Phase 4
37 A Trial Comparing the Effect of Oral Dimenhydrinate Versus Placebo in Children With Gastroenteritis Completed NCT00124787 Phase 4 Dimenhydrinate;Placebo
38 Emergency Department Rapid Intravenous Rehydration (RIVR) for Pediatric Gastroenteritis Completed NCT00392145 Phase 4 Standard IV rehydration;Rapid intravenous rehydration (RIVR)
39 Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis Completed NCT01467570 Phase 4
40 Efficacy of Lactobacillus GG With Diosmectite in Treatment Children With Acute Gastroenteritis Completed NCT01657032 Phase 4
41 Ondansetron Administration to WELL Children With Gastroenteritis Associated Vomiting in EDs in Pakistan Completed NCT01870635 Phase 4 Ondansetron;Placebo
42 Ondansetron Administration to Children With Gastroenteritis, Vomiting and SOME Dehydration in EDs in Pakistan Completed NCT01870648 Phase 4 Ondansetron;Placebo
43 Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants Completed NCT00779779 Phase 4
44 Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American Children Completed NCT02169817 Phase 4 Bacillus clausii;Oral Rehydration Therapy
45 Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab Completed NCT00737503 Phase 4
46 Impact of Four Patient Information Leaflets (PIL) on Patient Behaviour Completed NCT01398696 Phase 4
47 Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana Completed NCT01575197 Phase 4
48 Immunogenicity of Rotavirus Vaccine Completed NCT01199874 Phase 4
49 An Alternate Dosing Schedule for Pentavalent Rotavirus Vaccine (RotaTeq) Completed NCT01960725 Phase 4
50 The Treatment Effect of Bio-Three on Children With Enteritis Completed NCT01480947 Phase 4 Bio-three

Search NIH Clinical Center for Gastroenteritis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: gastroenteritis

Genetic Tests for Gastroenteritis

Anatomical Context for Gastroenteritis

MalaCards organs/tissues related to Gastroenteritis:

38
Colon, Testes, Bone, T Cells, Kidney, Small Intestine, Bone Marrow

Publications for Gastroenteritis

Articles related to Gastroenteritis:

(show top 50) (show all 1119)
# Title Authors Year
1
Genetic diversity and clonal characteristics of ciprofloxacin-resistant Campylobacter jejuni isolated from Chilean patients with gastroenteritis. ( 29306004 )
2018
2
Diarrheagenic Escherichia Coli and Acute Gastroenteritis in Children in Davidson County, Tennessee, United States: A Case-Control Study. ( 29341983 )
2018
3
Pilot survey of norovirus in Northern Italy: an example of surveillance of norovirus gastroenteritis. ( 29307329 )
2018
4
A Case of Eosinophilic Gastroenteritis in Which Obstructive Jaundice Developed due to Invagination of the Duodenal Wall. ( 29434146 )
2018
5
The NICE-GUT trial protocol: a randomised, placebo controlled trial of oral nitazoxanide for the empiric treatment of acute gastroenteritis among Australian Aboriginal children. ( 29391385 )
2018
6
Acute gastroenteritis: evidence-based management of pediatric patients [digest]. ( 29388753 )
2018
7
Rapid intravenous rehydration of children with acute gastroenteritis and dehydration: a systematic review and meta-analysis. ( 29426307 )
2018
8
New viruses associated with canine gastroenteritis. ( 29428093 )
2018
9
Eosinophilic gastroenteritis presenting with gastric perforation. ( 29366927 )
2018
10
Evaluation of a New Multiplex Real-Time PCR Assay for Detecting Gastroenteritis-Causing Viruses in Stool Samples. ( 29401556 )
2018
11
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy. ( 29438743 )
2018
12
Characterization of a Vesivirus Associated with an Outbreak of Acute Hemorrhagic Gastroenteritis in Domestic Dogs. ( 29444830 )
2018
13
Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo. ( 29397224 )
2018
14
Draft Genome Sequences of Two<i>Vibrio parahaemolyticus</i>Strains Associated with Gastroenteritis after Raw Seafood Ingestion in Colorado. ( 29348331 )
2018
15
Acute gastroenteritis: evidence-based management of pediatric patients. ( 29369591 )
2018
16
A life-devastating cause of gastroenteritis in an immunocompetent host: was it suspected? ( 29375867 )
2018
17
Complete Genome Sequence of a Novel Recombinant GII.P16-GII.1 Norovirus Associated with a Gastroenteritis Outbreak in Shandong Province, China, in 2017. ( 29439040 )
2018
18
Biochemical characterization of a catalase from Vibrio vulnificus, a pathogen that causes gastroenteritis. ( 28892106 )
2017
19
Diagnosis of eosinophilic gastroenteritis is easily missed. ( 28596692 )
2017
20
Eosinophilic Ascites: Uncommon Presentation of Eosinophilic Gastroenteritis in a Young Adult Male. ( 29255753 )
2017
21
Eosinophilic Ascites-Rarest Presentation of a Rare Disease, Eosinophilic Gastroenteritis. ( 29313586 )
2017
22
CCR3 Monoclonal Antibody Inhibits Eosinophilic Inflammation and Mucosal Injury in a Mouse Model of Eosinophilic Gastroenteritis. ( 28497923 )
2017
23
Red palms associated with adenovirus gastroenteritis. ( 28082320 )
2017
24
Lack of Knowledge and Low Readiness for Health Care Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. ( 28644350 )
2017
25
Time Trends and Predictors of Acute Gastroenteritis in the United States: Results From National Health and Nutrition Examination Survey 2005-2014. ( 28953059 )
2017
26
Targeted anthelmintic treatment of parasitic gastroenteritis in first grazing season dairy calves using daily live weight gain as an indicator. ( 28917324 )
2017
27
Gastroenteritis Aggressive Versus Slow Treatment For Rehydration (GASTRO). A pilot rehydration study for severe dehydration: WHO plan C versus slower rehydration. ( 28905004 )
2017
28
Eosinophilic gastroenteritis in a teenager: A rare diagnosis. ( 27283450 )
2017
29
Case of bullous pemphigoid accompanied by collagenous gastroenteritis. ( 28862318 )
2017
30
Eosinophilic gastroenteritis presenting as upper gastrointestinal hematoma and ulcers after endoscopic biopsy: A case report and literature review. ( 28906408 )
2017
31
Unparalleled patterns of intussusception and rotavirus gastroenteritis hospitalization rates among children younger than six years in Italy. ( 28067936 )
2017
32
Norovirus in feces and nasopharyngeal swab of children with and without acute gastroenteritis symptoms: First report of GI.5 in Brazil and GI.3 in nasopharyngeal swab. ( 28033513 )
2017
33
Rotavirus is frequent among adults hospitalised for acute gastroenteritis. ( 28007052 )
2017
34
Clinical Pathway Produces Sustained Improvement in Acute Gastroenteritis Care. ( 28882877 )
2017
35
Post-partum eosinophilic gastroenteritis: A case report. ( 28081983 )
2017
36
Analysis of Aichi virus and Saffold virus association with pediatric acute gastroenteritis. ( 27992789 )
2017
37
Serum Biomarkers for the Diagnosis of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis. ( 28943560 )
2017
38
Intravenous rehydration of malnourished children with acute gastroenteritis and severe dehydration: A systematic review. ( 28944301 )
2017
39
Prevalence of enteropathogens and their antibiotic sensitivity pattern in puppies with hemorrhagic gastroenteritis. ( 28919674 )
2017
40
Eosinophilic gastroenteritis caused by eating hens' eggs: A case report. ( 28279648 )
2017
41
The economic impact of childhood acute gastroenteritis on Malawian families and the healthcare system. ( 28871025 )
2017
42
Comparison of three multiplex gastrointestinal platforms for the detection of gastroenteritis viruses. ( 28889082 )
2017
43
Hematemesis as Initial Presentation in a 10-Week-Old Infant with Eosinophilic Gastroenteritis. ( 28299223 )
2017
44
Risk of acute gastroenteritis associated with human bocavirus infection in children: A systematic review and meta-analysis. ( 28910409 )
2017
45
Eosinophilic Gastroenteritis Presenting with Red Streaking. ( 28250308 )
2017
46
The Clinical Burden of Rotavirus Gastroenteritis: A Prospective Study. ( 29410942 )
2017
47
Immunogenicity of eGFP-Marked Recombinant Lactobacillus casei against Transmissible Gastroenteritis Virus and Porcine Epidemic Diarrhea Virus. ( 28946696 )
2017
48
Clinical and epidemiological characteristics in hospitalized young children with acute gastroenteritis in southern Taiwan: According to major pathogens. ( 28882583 )
2017
49
Idiopathic hypereosinophilic syndrome manifesting with eosinophilic cholecystitis and recurrent gastroenteritis. ( 28378039 )
2017
50
Bilateral hydronephrosis due to obstructive ureteral stone associated with norovirus gastroenteritis. ( 28588843 )
2017

Variations for Gastroenteritis

Expression for Gastroenteritis

Search GEO for disease gene expression data for Gastroenteritis.

Pathways for Gastroenteritis

Pathways related to Gastroenteritis according to GeneCards Suite gene sharing:

(show top 50) (show all 70)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.12 ANPEP CCL11 CDH1 CRP CXCL8 IFNA1
2
Show member pathways
13.86 CCL11 CDH1 CXCL8 IL10 IL1B IL4
3
Show member pathways
13.75 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
4
Show member pathways
13.66 CCL11 CDH1 CXCL8 IFNA1 IFNG IL10
5
Show member pathways
13.48 CCL11 CXCL8 IL10 IL1B IL4 IL5
6
Show member pathways
13.48 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
7
Show member pathways
13.41 CCL11 CDH1 CXCL8 IL10 IL1B IL4
8 12.96 CDH1 CXCL8 IFNA1 IFNG IL4 IL5
9
Show member pathways
12.92 CXCL8 IFNA1 IFNG IL1B IL4 IL6
10
Show member pathways
12.83 CXCL8 IFNA1 IFNG IL1B IL6 TNF
11
Show member pathways
12.74 IFNG IL10 IL1B IL4 IL5 IL6
12 12.69 IFNA1 IFNG IL10 IL1B IL4 TNF
13
Show member pathways
12.67 CXCL8 IFNA1 IFNG IL10 IL1B IL6
14
Show member pathways
12.66 IFNG IL10 IL1B IL6 TNF
15
Show member pathways
12.64 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
16
Show member pathways
12.57 IFNG IL10 IL1B IL4 IL5 IL6
17
Show member pathways
12.51 IFNA1 IFNG IL10 IL4 IL5 IL6
18
Show member pathways
12.46 ALB CRP IFNG IL1B IL4 IL6
19
Show member pathways
12.41 CCL11 CXCL8 IFNG IL1B IL4 IL5
20
Show member pathways
12.4 CXCL8 IFNG IL1B IL6 TNF
21
Show member pathways
12.38 IFNG IL10 IL1B IL4 TNF
22 12.38 IFNA1 IFNG IL10 IL1B IL6 TNF
23 12.31 CXCL8 IL10 IL1B IL6 TNF
24
Show member pathways
12.29 CCL11 CXCL8 IFNG IL1B IL4 IL6
25
Show member pathways
12.28 IFNA1 IFNG IL1B TNF
26 12.26 CDH1 IFNG IL6 TNF
27 12.16 CXCL8 IFNG IL1B IL4 IL6 TNF
28 12.1 ANPEP IFNG IL10 IL4 IL5 IL6
29
Show member pathways
12.09 IFNG IL10 IL1B IL6 TNF
30 12.06 CCL11 CXCL8 IL10 IL1B IL4 IL6
31 12.05 CXCL8 IFNG IL1B IL6
32 12.03 ANPEP IL1B IL4 IL5 IL6 TNF
33 12.02 CXCL8 IFNG IL1B IL6 TNF
34 12.02 CXCL8 IFNG IL10 IL1B IL6 TNF
35 12.01 CXCL8 IL1B IL6 TNF
36
Show member pathways
11.97 IFNG IL1B IL4 IL6
37 11.97 CXCL8 IFNG IL4 IL5 IL6
38 11.95 CXCL8 IFNG IL1B IL6
39 11.94 IFNA1 IFNG IL10 IL6
40
Show member pathways
11.92 CXCL8 IFNG IL4 IL5 TNF
41 11.92 CXCL8 IL10 IL1B IL6 TNF
42 11.92 IFNG IL10 IL1B IL4 IL5 TNF
43 11.86 CDH1 IFNG IL10 IL1B IL6 TNF
44 11.85 IL10 IL4 IL5 IL6 TNF
45
Show member pathways
11.82 CXCL8 IFNA1 IFNG IL10 IL1B IL4
46
Show member pathways
11.81 CXCL8 IFNG IL1B IL6 TNF
47 11.8 CCL11 IL10 IL4 IL5
48 11.74 CXCL8 IL1B IL6 TNF
49 11.66 CXCL8 IFNG IL6
50 11.66 CCL11 IFNG IL10 IL4 IL5

GO Terms for Gastroenteritis

Cellular components related to Gastroenteritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.8 ALB CCL11 CDH1 CRP CXCL8 IFNA1
2 extracellular space GO:0005615 9.47 ALB ANPEP CCL11 CRP CXCL8 IFNA1

Biological processes related to Gastroenteritis according to GeneCards Suite gene sharing:

(show all 35)
# Name GO ID Score Top Affiliating Genes
1 cytokine-mediated signaling pathway GO:0019221 9.88 IFNA1 IL1B IL5 IL6
2 cellular response to lipopolysaccharide GO:0071222 9.84 CXCL8 IL10 IL6 TNF
3 regulation of insulin secretion GO:0050796 9.83 IFNG IL1B TNF
4 B cell differentiation GO:0030183 9.83 IFNA1 IL10 IL4
5 neutrophil chemotaxis GO:0030593 9.81 CCL11 CXCL8 IL1B
6 response to glucocorticoid GO:0051384 9.81 IL10 IL6 TNF
7 positive regulation of T cell proliferation GO:0042102 9.8 IL1B IL4 IL6
8 defense response to Gram-positive bacterium GO:0050830 9.8 CRP IL6 RNASE3 TNF
9 positive regulation of interleukin-6 production GO:0032755 9.77 IL1B IL6 TNF
10 inflammatory response GO:0006954 9.76 CCL11 CRP CXCL8 IL10 IL1B IL5
11 positive regulation of nitric oxide biosynthetic process GO:0045429 9.74 IFNG IL1B TNF
12 humoral immune response GO:0006959 9.73 IFNA1 IFNG IL6 TNF
13 positive regulation of DNA binding transcription factor activity GO:0051091 9.72 IL10 IL1B IL5 IL6 TNF
14 response to molecule of bacterial origin GO:0002237 9.67 CXCL8 IL10
15 positive regulation of podosome assembly GO:0071803 9.66 IL5 TNF
16 positive regulation of immunoglobulin secretion GO:0051024 9.66 IL5 IL6
17 positive regulation of chemokine biosynthetic process GO:0045080 9.65 IL1B TNF
18 positive regulation of membrane protein ectodomain proteolysis GO:0051044 9.65 IFNG IL1B TNF
19 endothelial cell apoptotic process GO:0072577 9.64 IL10 TNF
20 regulation of establishment of endothelial barrier GO:1903140 9.62 IL1B TNF
21 positive regulation of MHC class II biosynthetic process GO:0045348 9.62 IL10 IL4
22 negative regulation of cytokine secretion involved in immune response GO:0002740 9.61 IL10 TNF
23 immune response GO:0006955 9.61 CCL11 CXCL8 IFNG IL10 IL1B IL4
24 type 2 immune response GO:0042092 9.6 IL10 IL4
25 positive regulation of fever generation GO:0031622 9.58 IL1B TNF
26 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.58 IL10 IL1B TNF
27 sequestering of triglyceride GO:0030730 9.56 IL1B TNF
28 regulation of isotype switching GO:0045191 9.55 IL10 IL4
29 negative regulation of lipid storage GO:0010888 9.54 CRP IL6 TNF
30 receptor biosynthetic process GO:0032800 9.52 IL10 TNF
31 positive regulation of vitamin D biosynthetic process GO:0060557 9.51 IFNG TNF
32 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.43 IFNG IL1B TNF
33 regulation of receptor activity GO:0010469 9.32 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
34 positive regulation of gene expression GO:0010628 10.01 CRP IFNG IL1B IL6 TNF
35 positive regulation of transcription, DNA-templated GO:0045893 10 CDH1 IL10 IL1B IL4 IL5 IL6

Molecular functions related to Gastroenteritis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.32 CCL11 CXCL8 IFNA1 IFNG IL10 IL1B
2 growth factor activity GO:0008083 9.26 IL10 IL4 IL5 IL6

Sources for Gastroenteritis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
14